Oncology Institute, Inc. Income Statement

Income Statement Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 187.51M203.00M252.48M324.24M393.41M
Cost of Revenue 95.75M99.40M134.76M181.02M186.88M
Gross Profit 91.77M103.60M117.72M143.22M206.53M
Operating items
Depreciation & Amortization - Total 0.69M0.83M1.53M2.86M3.19M
Selling, General & Administrative 41.90M83.36M119.69M113.85M107.83M
Other Operating Expenses 153.12M164.67M213.22M284.54M342.51M
Operating Expenses 195.71M248.86M334.43M401.26M453.53M
Operating Income -8.20M-45.86M-81.95M-77.02M-60.12M
EBIT -8.20M-45.86M-81.95M-77.02M-60.12M
Non-operating items
Interest & Investment Income 0.25M
Other Non Operating Income -6.27M4.96M24.20M0.88M2.70M
Non Operating Income -6.62M34.26M81.86M-6.09M-4.54M
Net income details
EBT -14.81M-11.60M-0.09M-83.10M-64.66M
Tax Provisions -0.49M-0.67M-0.24M-0.04M
Profit After Tax -14.32M-10.93M0.15M-83.07M-64.66M
Income from Continuing Operations -14.32M-10.93M0.15M-83.07M-64.66M
Consolidated Net Income -14.32M-10.93M0.15M-83.07M-64.66M
Income towards Parent Company -14.32M-10.93M0.15M-83.07M-64.66M
Net Income towards Common Stockholders -6.40M-10.63M-16.98M-67.88M-53.01M
Additional items
EPS (Basic) -0.24-0.16-0.23-0.92-0.71
EPS (Weighted Average and Diluted) -0.24-0.16-0.21-0.92-0.71
Shares Outstanding (Weighted Average) 28.75M73.25M72.34M73.75M75.75M
Shares Outstanding (Diluted Average) 59.12M66.23M80.61M73.75M75.04M
EBITDA -7.51M-45.03M-80.42M-74.15M-56.93M
Interest Expenses 0.35M0.32M6.78M7.50M
Tax Rate 3.33%5.79%0.04%